Bristol-Myers
Squibb Company (NYSE:BMY) today announced that its Board of
Directors has elected Peter J. Arduini to the Board, effective April 1,
2016. Mr. Arduini will serve as a member of the Audit Committee of the
Board of Directors, effective May 3, 2016.
Mr. Arduini, 51, is currently president and chief executive officer and
director of Integra LifeSciences (NASDAQ:IART), a leading global medical
technology company. He joined Integra LifeSciences in 2010 as president
and chief operating officer and director, and was named CEO in 2012. Mr.
Arduini brings more than 25 years of global experience in medical device
technology and pharmaceutical businesses, and has led operations in
China, Europe, Japan and the U.S. Before joining Integra, Mr. Arduini
was corporate vice president and president of Medication Delivery,
Baxter Healthcare, which he joined in 2005. At Baxter, he was
responsible for a portfolio focused on the inpatient acute care hospital
market. Prior to joining Baxter, Mr. Arduini was responsible for the
functional imaging business at General Electric Healthcare, where he
spent 15 years assuming increasing levels of responsibility. Mr. Arduini
serves on the Board of Directors of ADVAMED, the Advanced Medical
Technology Association, and MDIC, the Medical Device Innovation
Consortium. Mr. Arduini received his bachelor's degree in marketing from
Susquehanna University and a master's in management from Northwestern
University's Kellogg School of Management.
“Pete is a confident and engaging leader who has delivered tremendous
results throughout his career,” said Lamberto
Andreotti, chairman, Bristol-Myers Squibb. “His commercial,
financial and operational experience, along with a deep understanding of
healthcare, make him an ideal choice for our Board. I look forward to
his contributions.”
“Pete brings significant healthcare experience, unwavering integrity and
a focus on helping patients,” said Giovanni
Caforio, M.D., chief executive officer, Bristol-Myers Squibb.
“Bristol-Myers Squibb will benefit from his insights as a strategic
leader, and I am excited to have him join our Board.”
About Bristol-Myers Squibb
Bristol-Myers Squibb is a global biopharmaceutical company whose mission
is to discover, develop and deliver innovative medicines that help
patients prevail over serious diseases. For more information about
Bristol-Myers Squibb, visit us at BMS.com
or follow us on LinkedIn,
Twitter, and YouTube.
